Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective

Documenti analoghi

• Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
  di: Jie Chen, et al.
  Pubblicazione: (2025)
• Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
  di: Jie Chen, et al.
  Pubblicazione: (2025)
• Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
  di: Chen, Jie, et al.
  Pubblicazione: (2024)
• Sensitivity Analysis for Unmeasured Confounding in Medical Product Development and Evaluation Using Real World Evidence
  di: Fang, Yixin, et al.
  Pubblicazione: (2023)
• Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
  di: Chen, Jie, et al.
  Pubblicazione: (2024)